Featured Products

ADC ASSAYS

Assay Solutions for ADCs

Cell-based Assays for Screening and Characterization of Antibody Drug Conjugates (ADCs)

GPCR PROTEINS

Recombinant GPCR Proteins

Active, Purified Full-length GPCRs for Ligand Discovery, Structural Biology, & MOA Studies

OBESITY/DIABETES ASSAYS

GLP-1, GIP, AMY, GCG, & More!

MOA-reflective Assays to Accelerate Next-generation Therapeutics Development for Obesity and Diabetes

What's New

Image
WHITE PAPERS

GPCR Functional ‘Volume Control’ in Cell Systems: Tuning Receptor Density & System Sensitivity to Define Compound Activity

Image
Image
FLYER & BROCHURES

New Eurofins DiscoverX Products (launched in July)

Image
Image
BLOGS

Choosing the Right Calcium Assay Readout for Measuring GPCR Activation

Image
Image
VIDEOS

Virtual Site Tour: Explore the Eurofins DiscoverX San Francisco Bay Area Labs

Image
thumbnailImg
WHITE PAPERS

GPCR Functional ‘Volume Control’ in Cell Systems: Tuning Receptor Density & System Sensitivity to Define Compound Activity

How much of your compound's activity are your assays really detecting? Understanding how receptor density impacts pharmacological responses is critical for accurately characterizing compound activity & identifying candidates with the highest likelihood of therapeutic success. Review the latest GPCR white paper, "Functional 'Volume Control' in Cell Systems," by GPCR expert Terry Kenakin, Ph.D., Professor of Pharmacology at the University of North Carolina School of Medicine, in collaboration with Eurofins DiscoverX®. The white paper explores how tuning receptor density & system sensitivity can uncover hidden efficacies, improve characterization of agonists & antagonists, & provide more predictive pharmacology.

LEARN MORE

Stay current on our latest innovations, products, and science news in our weekly Drug Discovery and Development Email Newsletter. Subscribe today and tap into our most recent products and assets.

Latest News & Insights